The limited proliferative potential (cellular senescence) of normal human cells in culture has provided an important model for the study of aging at the cellular level. The model has been validated by various data, including the fact that cells from individuals that exhibit premature aging have lower division capability. Evidence that genetic events rather than random damage results in senescence has come from somatic cell hybridization studies which have shown that the senescent phenotype is dominant in hybrids between young and senescent, as well as normal and immortal human cells. In addition, convincing evidence has been obtained to indicate that senescent cells express a surface membrane associated protein inhibitor of initiation of DNA synthesis that is not present in young cells. We hypothesized that expression of this inhibitor is the endpoint of the genetic events resulting in senescence. We have demonstrated by microinjection that DNA synthesis inhibitory mRNA is highly abundant in senescent but not young cells, suggesting the feasibility of cloning the cDNA encoding the inhibitor. We have recently cloned three cDNAs derived from senescent cells by an expression screening approach. These are called sdi or senescent cell derived inhibitors. One clone is expressed at approximately 10 fold higher levels in senescent and quiescent cells compared to cycling young cells. Quiescent cells have been shown to express a protein inhibitor of DNA synthesis with some, but not all, properties of that produced by senescent cells. sdi1 is therefore a good candidate for the gene encoding the protein inhibitor(s) of DNA synthesis. Alternatively, sdi1 could be coding for an inhibitor of DNA synthesis that has not been previously identified as the cDNA sequence has no significant homology to sequences present in GenBank and the EMBL databases. The goals of this proposal are to elucidate the mechanisms of action of sdi1 and to determine its role during in vitro and in vivo aging.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
1R01AG011066-01
Application #
3123056
Study Section
Molecular Cytology Study Section (CTY)
Project Start
1992-09-30
Project End
1995-07-31
Budget Start
1992-09-30
Budget End
1993-07-31
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Dimri, G P; Nakanishi, M; Desprez, P Y et al. (1996) Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol Cell Biol 16:2987-97
Smith, J R; Nakanishi, M; Robetorye, R S et al. (1996) Studies demonstrating the complexity of regulation and action of the growth inhibitory gene SDI1. Exp Gerontol 31:327-35
Yang, L; Didenko, V V; Noda, A et al. (1995) Increased expression of p21Sdi1 in adrenocortical cells when they are placed in culture. Exp Cell Res 221:126-31
Nakanishi, M; Robetorye, R S; Pereira-Smith, O M et al. (1995) The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition. J Biol Chem 270:17060-3
Khaoustov, V I; Ozer, A; Smith, J R et al. (1995) Induction of senescent cell-derived inhibitor of DNA synthesis gene, SDI1, in hepatoblastoma (HepG2) cells arrested in the G2-phase of the cell cycle by 9-nitrocamptothecin. Lab Invest 73:118-27
Nakanishi, M; Robetorye, R S; Adami, G R et al. (1995) Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1. EMBO J 14:555-63
Aggarwal, B B; Totpal, K; LaPushin, R et al. (1995) Diminished responsiveness of senescent normal human fibroblasts to TNF-dependent proliferation and interleukin production is not due to its effect on the receptors or on the activation of a nuclear factor NF-kappa B. Exp Cell Res 218:381-8
Goletz, T J; Smith, J R; Pereira-Smith, O M (1994) Molecular genetic approaches to the study of cellular senescence. Cold Spring Harb Symp Quant Biol 59:59-66
Johnson, M; Dimitrov, D; Vojta, P J et al. (1994) Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/p21 RNA in human cells. Mol Carcinog 11:59-64
Harper, J W; Adami, G R; Wei, N et al. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-16